Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Kura Oncology, Inc.
Augusta University
Dana-Farber Cancer Institute
University of Colorado, Denver
Dana-Farber Cancer Institute
Children's Hospital of Philadelphia
M.D. Anderson Cancer Center
Ascentage Pharma Group Inc.
Fred Hutchinson Cancer Center
BlossomHill Therapeutics
Masonic Cancer Center, University of Minnesota
Peking University People's Hospital
Cogent Biosciences, Inc.
University of Rochester
Affiliated Hospital of Nantong University